| scholarly article | Q13442814 |
| P2093 | author name string | Christopher B Shields | |
| Darlene A Burke | |||
| Lisa B E Shields | |||
| Rebecca Gray | |||
| Yi Ping Zhang | |||
| P2860 | cites work | Regrowth of axons into the distal spinal cord through a Schwann-cell-seeded mini-channel implanted into hemisected adult rat spinal cord. | Q48228432 |
| Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue | Q48313494 | ||
| Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. | Q48561046 | ||
| Oligodendrocytes arrest neurite growth by contact inhibition. | Q48843200 | ||
| Regenerative Nerve Fiber Growth in the Adult Central Nervous System | Q48857473 | ||
| Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels | Q49044172 | ||
| A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. | Q51039622 | ||
| Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. | Q51451500 | ||
| Dural closure, cord approximation, and clot removal: enhancement of tissue sparing in a novel laceration spinal cord injury model. | Q51692148 | ||
| Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. | Q52170285 | ||
| Chronic Enhancement of the Intrinsic Growth Capacity of Sensory Neurons Combined with the Degradation of Inhibitory Proteoglycans Allows Functional Regeneration of Sensory Axons through the Dorsal Root Entry Zone in the Mammalian Spinal Cord | Q58429249 | ||
| Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors | Q60223546 | ||
| Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes | Q67703308 | ||
| Axonal growth on astrocytes is not inhibited by oligodendrocytes | Q67982457 | ||
| Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars | Q71815667 | ||
| Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation | Q73343119 | ||
| Brain derived versican V2 is a potent inhibitor of axonal growth | Q73441516 | ||
| Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord | Q75445653 | ||
| PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration | Q75447896 | ||
| Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord | Q78003481 | ||
| Increased expression of the putative axon growth-repulsive extracellular matrix molecule, keratan sulphate proteoglycan, following traumatic injury of the adult rat spinal cord | Q78457828 | ||
| Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord | Q79892954 | ||
| Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury | Q80242034 | ||
| Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein | Q22253157 | ||
| Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration | Q24290847 | ||
| The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury | Q28191612 | ||
| Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth | Q28204972 | ||
| Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor | Q28207833 | ||
| Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth | Q28216797 | ||
| Regeneration beyond the glial scar | Q28239915 | ||
| Regeneration of adult axons in white matter tracts of the central nervous system | Q28257832 | ||
| Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue | Q28566378 | ||
| Chondroitinase ABC promotes functional recovery after spinal cord injury | Q29615017 | ||
| Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans | Q33767291 | ||
| Progress in spinal cord research - a refined strategy for the International Spinal Research Trust | Q34016624 | ||
| Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury | Q34249936 | ||
| Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration | Q34309248 | ||
| Ephrin signaling in axon guidance | Q34347809 | ||
| Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth | Q34527751 | ||
| Extracellular matrix in spinal cord regeneration: getting beyond attraction and inhibition | Q34585719 | ||
| Nogo and the Nogo-66 receptor | Q35002832 | ||
| New roles for old proteins in adult CNS axonal regeneration | Q35069019 | ||
| Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury | Q35090882 | ||
| Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans | Q38352913 | ||
| Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. | Q38524950 | ||
| Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. | Q40868923 | ||
| NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. | Q40914375 | ||
| Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. | Q40923776 | ||
| Cell adhesion molecules and neuronal regeneration | Q40924693 | ||
| Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth | Q41440802 | ||
| Glial cell extracellular matrix: boundaries for axon growth in development and regeneration | Q41606080 | ||
| Elimination of basal lamina and the collagen "scar" after spinal cord injury fails to augment corticospinal tract regeneration | Q41713434 | ||
| Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. | Q42140143 | ||
| Laminin overrides the inhibitory effects of peripheral nervous system and central nervous system myelin-derived inhibitors of neurite growth | Q42514334 | ||
| Inhibitory proteoglycan immunoreactivity is higher at the caudal than the rostral Schwann cell graft-transected spinal cord interface | Q43556178 | ||
| Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition | Q43560231 | ||
| Excitotoxic model of post-traumatic syringomyelia in the rat. | Q43745752 | ||
| Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. | Q43974980 | ||
| Ascending sensory, but not other long-tract axons, regenerate into the connective tissue matrix that forms at the site of a spinal cord injury in mice | Q44481450 | ||
| Synergistic effects of brain-derived neurotrophic factor and chondroitinase ABC on retinal fiber sprouting after denervation of the superior colliculus in adult rats. | Q44540533 | ||
| NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. | Q46345563 | ||
| Axonal Regeneration through Regions of Chondroitin Sulfate Proteoglycan Deposition after Spinal Cord Injury: A Balance of Permissiveness and Inhibition | Q46479010 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 568-77; discussion 577 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | World Neurosurgery | Q15765829 |
| P1476 | title | Benefit of chondroitinase ABC on sensory axon regeneration in a laceration model of spinal cord injury in the rat | |
| P478 | volume | 69 |
| Q35127473 | A systematic review of directly applied biologic therapies for acute spinal cord injury |
| Q37718952 | Astrocytic and vascular remodeling in the injured adult rat spinal cord after chondroitinase ABC treatment |
| Q49050144 | Basic techniques for long distance axon tracing in the spinal cord |
| Q28555030 | Chondroitinase C Selectively Degrades Chondroitin Sulfate Glycosaminoglycans that Inhibit Axonal Growth within the Endoneurium of Peripheral Nerve |
| Q40419695 | Combined chondroitinase and KLF7 expression reduce net retraction of sensory and CST axons from sites of spinal injury |
| Q37247610 | Dorsal column sensory axons degenerate due to impaired microvascular perfusion after spinal cord injury in rats |
| Q42840267 | Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats |
| Q96128596 | Evaluating Chondroitin Sulfate and Dermatan Sulfate Expression in Glial Scar to Determine Appropriate Intervention Time in Rats |
| Q37928624 | Extracellular matrix and perineuronal nets in CNS repair |
| Q38716618 | In vitro models of axon regeneration |
| Q35783366 | Local Delivery of High-Dose Chondroitinase ABC in the Sub-Acute Stage Promotes Axonal Outgrowth and Functional Recovery after Complete Spinal Cord Transection |
| Q38179520 | Manipulating the extracellular matrix and its role in brain and spinal cord plasticity and repair |
| Q37061055 | Migration of Adipose-derived Mesenchymal Stem Cells Stably Expressing Chondroitinase ABC In vitro |
| Q36125734 | Phenotypic Screening of Small-Molecule Inhibitors: Implications for Therapeutic Discovery and Drug Target Development in Traumatic Brain Injury |
| Q57460363 | Regenerative Strategies for the Central Nervous System |
| Q37677472 | Spinal Cord Injury and Related Clinical Trials |
| Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
Search more.